These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 4299219

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of glucose and tolbutamide-induced insulin release by iodoacetate and antimycin A.
    Georg RH, Sussman KE, Leitner JW, Kirsch WM.
    Endocrinology; 1971 Jul; 89(1):169-76. PubMed ID: 4930775
    [No Abstract] [Full Text] [Related]

  • 27. [Hyperglycemic and insulin-depressing effect of diazoxide in a case of hyperinsulinism caused by beta-insular hyperplasia].
    Brunetti P, Santeusanio F, Arena D, Palumbo R, Puxeddu A, De Ciuceis P, Calabrese G.
    Clin Ter; 1971 Feb 15; 56(3):213-27. PubMed ID: 4931943
    [No Abstract] [Full Text] [Related]

  • 28. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
    Song SH, Rhodes CJ, Veldhuis JD, Butler PC.
    Endocrinology; 2003 Aug 15; 144(8):3399-405. PubMed ID: 12865318
    [Abstract] [Full Text] [Related]

  • 29. The morphological substrate of the inhibition of insulin secretion by diazoxide.
    Creutzfeldt W, Creutzfeldt C, Frerichs H, Perings E, Sicklinger K.
    Horm Metab Res; 1969 Mar 15; 1(2):53-64. PubMed ID: 4334867
    [No Abstract] [Full Text] [Related]

  • 30. Biochemical aspects of the hyperglycemic action of diazoxide.
    Senft G.
    Ann N Y Acad Sci; 1968 Apr 11; 150(2):242-55. PubMed ID: 4299217
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The mode of action of adenosine 3':5'-cyclic monophosphate in mammalian islets of Langerhans. Effects of insulin secretagogues on islet-cell protein kinase activity.
    Montague W, Howell SL.
    Biochem J; 1973 May 11; 134(1):321-7. PubMed ID: 4353086
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Inhibition of insulin secretion by alpha adrenergic stimulatory agents].
    Senft G, Sitt R, Losert W, Schultz G, Hoffmann M.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968 May 11; 260(4):309-23. PubMed ID: 4300750
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.